1) Durand M. Microbiologic factors and visual outcome in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol 1997;124:127-30.
2) Benz MS, Scott IU, Flynn HW Jr, et al. Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases. Am J Ophthalmol 2004;137:38-42.
3) Friling E, Lundström M, Stenevi U, Montan P. Six-year incidence of endophthalmitis after cataract surgery: Swedish national study. J Cataract Refract Surg 2013;39:15-21.
4) Kim HW, Kim SY, Chung IY, et al. Emergence of Enterococcus species in the infectious microorganisms cultured from patients with endophthalmitis in South Korea. Infection 2014;42:113-8.
9) Gulhan T, Boynukara B, Ciftci A, et al. Characterization of Enterococcus faecalis isolates originating from different sources for their virulence factors and genes, antibiotic resistance patterns, genotypes and biofilm production. Iran J Vet Res 2015;16:261-6.
11) Seal DV, Barry P, Gettinby G, et al. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: case for a European multicenter study. J Cataract Refract Surg 2006;32:396-406.
12) Barry P, Seal DV, Gettinby G, et al. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: preliminary report of principal results from a European multicenter study. J Cataract Refract Surg 2006;32:407-10.
13) Dave VP, Pathengay A, Braimah IZ, et al. Enterococcus endophthalmitis: clinical settings, antimicrobial susceptibility, and management outcomes. Retina 2020;40:898-902.
15) Armin S, Fallah F, Karimi A, et al. Genotyping, antimicrobial resistance and virulence factor gene profiles of vancomycin resistance Enterococcus faecalis isolated from blood culture. Microb Pathog 2017;109:300-4.
16) Sun Y, Lu H, Zhang X, et al. Phenotype and genotype alteration during adaptive evolution of Enterococcus faecalis to antimicrobials. Infect Genet Evol 2018;62:80-5.
17) Todokoro D, Eguchi H, Suzuki T, et al. Genetic diversity and persistent colonization of Enterococcus faecalis on ocular surfaces. Jpn J Ophthalmol 2018;62:699-705.
19) Todokoro D, Suzuki T, Kobayakawa S, et al. Postoperative Enterococcus faecalis endophthalmitis: virulence factors leading to poor visual outcome. Jpn J Ophthalmol 2017;61:408-14.
21) Hällgren A, Abednazari H, Ekdahl C, et al. Antimicrobial susceptibility patterns of Enterococci in intensive care units in Sweden evaluated by different MIC breakpoint systems. J Antimicrob Chemother 2001;48:53-62.
22) Ishikawa K, Hamasuna R, Uehara S, et al. Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases. J Infect Chemother 2015;21:623-33.
23) NHIS. A study on the use of antibacterial agents in Korea and the resistance of major pathogens to antibacterial agents. Goyang: NHIS (KR), 2016;116.Report No.: 2016-20-001.
26) Coburn PS, Gilmore MS. The Enterococcus faecalis cytolysin: a novel toxin active against eukaryotic and prokaryotic cells. Cell Microbiol 2003;5:661-9.
29) Barbosa-Ribeiro M, De-Jesus-Soares A, Zaia AA, et al. Antimicrobial susceptibility and characterization of virulence genes of enterococcus faecalis isolates from teeth with failure of the endodontic treatment. J Endod 2016;42:1022-8.
30) Torelli R, Serror P, Bugli F, et al. The PavA-like fibronectin-binding protein of Enterococcus faecalis, EfbA, is important for virulence in a mouse model of ascending urinary tract infection. J Infect Dis 2012;206:952-60.
32) Kowalski RP, Yates KA, Romanowski EG, et al. An ophthalmologist’s guide to understanding antibiotic susceptibility and minimum inhibitory concentration data. Ophthalmology 2005;112:1987.